Royal Bank of Canada
XGN icon

Royal Bank of Canada’s Exagen XGN Stock Holding History

Royal Bank of Canada’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Sell
312
-1,156
-79% -$4.47K ﹤0.01% 6975
2025
Q4 		$9K Sell
1,468
-3,132
-68% -$28.5K ﹤0.01% 6490
2025
Q3 		$50K Sell
4,600
-1,225
-21% -$10.8K ﹤0.01% 5821
2025
Q2 		$40K Buy
5,825
+5,139
+749% +$31.2K ﹤0.01% 6013
2025
Q1 		$2K Buy
686
+351
+105% +$1.32K ﹤0.01% 6603
2024
Q4 		$1K Buy
+335
New +$1.21K ﹤0.01% 6823
2024
Q3 		– Sell
-237
Closed – – 7531
2024
Q2 		$0 Buy
237
+149
+169% +$252 ﹤0.01% 7601
2024
Q1 		$0 Sell
88
-454
-84% -$881 ﹤0.01% 7673
2023
Q4 		$1K Sell
542
-3,165
-85% -$5.47K ﹤0.01% 7002
2023
Q3 		$9K Buy
3,707
+564
+18% +$1.43K ﹤0.01% 6472
2023
Q2 		$9K Buy
3,143
+2,977
+1,793% +$8.47K ﹤0.01% 6515
2023
Q1 		$0 Sell
166
-1
-0.6% -$3 ﹤0.01% 7552
2022
Q4 		$0 Sell
167
-61
-27% -$156 ﹤0.01% 7791
2022
Q3 		$1K Buy
228
+94
+70% +$524 ﹤0.01% 7293
2022
Q2 		$1K Sell
134
-651
-83% -$3.79K ﹤0.01% 7226
2022
Q1 		$6K Sell
785
-1,423
-64% -$12.3K ﹤0.01% 7205
2021
Q4 		$26K Buy
2,208
+914
+71% +$10.7K ﹤0.01% 6686
2021
Q3 		$18K Buy
1,294
+548
+73% +$7.29K ﹤0.01% 6750
2021
Q2 		$11K Buy
746
+345
+86% +$5.29K ﹤0.01% 6847
2021
Q1 		$7K Buy
401
+94
+31% +$1.68K ﹤0.01% 6961
2020
Q4 		$4K Buy
307
+295
+2,458% +$4.17K ﹤0.01% 6753
2020
Q3 		$0 Sell
12
-19
-61% -$245 ﹤0.01% 6968
2020
Q2 		$0 Sell
31
-600
-95% -$8.12K ﹤0.01% 6947
2020
Q1 		$10K Buy
631
+430
+214% +$8.53K ﹤0.01% 5838
2019
Q4 		$5K Buy
+201
New +$3.58K ﹤0.01% 6372

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Royal Bank of Canada's XGN Position: Q1 2026 in Review

Royal Bank of Canada reduced its Exagen (XGN) stake by 79% in Q1 2026, selling an estimated $4.47K and leaving 312 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6975.

Royal Bank of Canada first reported a position in XGN in Q4 2019 and has held it in 25 quarters since. The position peaked at $50K in Q3 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Royal Bank of Canada held 312 shares of Exagen worth $1K as of Q1 2026.
  • Royal Bank of Canada sold 1,156 Exagen shares in Q1 2026, an estimated $4.47K.
  • Exagen made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6975 holding.
  • Royal Bank of Canada first reported a position in Exagen in Q4 2019 and has held it in 25 quarters since.
  • Royal Bank of Canada's Exagen position peaked at $50K in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.